With recent FDA approvals of immunotherapy drugs for kidney and bladder cancer, patients now have more options to consider among their treatments. The 2016 ASCO annual meeting featured several new developments in these two cancers that seem to keep the momentum moving forward in this field. We asked Charles Drake, M.D., Ph.D., associate director of(...)
Research
Avon awards Kimmel Cancer Center more than $1 million for breast cancer research and support
Posted by | ResearchThis past weekend, the Avon Foundation held its 14th annual event in Washington, D.C. to raise funds for breast cancer research and education. More than 1,900 participants from 41 states and Washington, D.C. walked 39.3 miles in the AVON 39 The Walk to End Breast Cancer. Of the total $4.8 million raised during the weekend event,(...)
Perspective on a breast cancer genome sequencing study
Posted by | ResearchIn today's lineup of stories covered by WNYC's radio program The Takeaway, Kimmel Cancer Center expert Josh Lauring, M.D., Ph.D., provides his perspective on a new study published yesterday in the journal Nature by the Wellcome Trust Sanger Institute. The study is an analysis of the genomic sequencing of 560 breast cancer patients. Listen to Lauring and radio host John(...)
One-third of patients with metastatic melanoma treated with immunotherapy drug nivolumab survive five years
Posted by | ResearchAt the 2016 American Association for Cancer Research annual meeting today, scientists presented their results of a follow-up study tracking the survival of metastatic melanoma patients who were treated with the immunotherapy drug nivolumab. The drug is currently approved by the U.S. Food and Drug Administration for advanced lung and kidney cancers and advanced melanomas.(...)
Possibilities – Bloomberg~Kimmel Institute for Cancer Immunotherapy
Posted by | Research"I, along with the other cancer patients and survivors, have waited more than 20 years to see this day arrive," says Johns Hopkins champion Sidney Kimmel. Learn more about the Bloomberg~Kimmel Institute for Cancer Immunotherapy.
Shaping the Future of Cancer Research Training
Posted by | Research**This blog post was written by Kimmel Cancer Center development coordinator Allison Rich. Ben Park, M.D., Ph.D., was recently named the Johns Hopkins Kimmel Cancer Center’s associate director for research training and education. Already an internationally recognized physician-scientist committed to training and mentoring young students and faculty members, Park’s new role allows him to even(...)
A Conversation about Cancer: Six Questions that Keep Cancer Experts Up at Night
Posted by | Research, UncategorizedWhat keeps you up at night? This was the question posed by Kimmel Cancer Center director William Nelson, M.D., Ph.D., to six cancer experts who participated in a Cancer Conversations forum on Nov. 3, 2015. In parts one and two of this series, they predicted the future of cancer medicine and discussed how they collaborate(...)
A Conversation about Cancer: How We Collaborate
Posted by | Research, UncategorizedIn part one of this series, experts at the Johns Hopkins Kimmel Cancer Center discussed their predictions for the future of cancer medicine during a Cancer Conversations forum on Nov. 3, 2015. These experts also discussed how they collaborate with other scientists. On the panel were: Kimmel Professor and Director of Radiation Oncology and Molecular(...)
A Conversation about Cancer
Posted by | precision medicine, Prevention/Screening, Research, UncategorizedOn Nov. 3, 2015, a capacity crowd of more than 250 Johns Hopkins leaders, faculty, staff, students, donors, and other guests filled the Albert H. Owens Auditorium at the Johns Hopkins Kimmel Cancer Center to honor the philanthropy of Sidney Kimmel for advancing cancer discovery and care. Hundreds more watched via video streaming as Kimmel(...)
New therapies, clinical trials and innovations in lung cancer care mean “hope is on the rise”
Posted by | Research“We are at a crossroads, a time of discovery that’s transforming the ways we manage lung cancer,” says radiation oncologist Russell K. Hales, M.D. of the Johns Hopkins Kimmel Cancer Center on the Johns Hopkins Bayview campus. “Lung cancer is simply not the same disease we had 10 years ago, in terms of the tools(...)